Panobinostat (LBH589) inhibits Wnt/beta-catenin signaling pathway via upregulating APCL expression in breast cancer

Qin, G; Li, YZ; Xu, XD; Wang, X; Zhang, K; Tang, YL; Qiu, HJ; Shi, DB; Zhang, CL; Long, Q; Lee, KP; Zhai, QL; Wang, SS; Chen, M; Deng, WG

Chen, M; Deng, WG (reprint author), Sun Yat Sen Univ, Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China.

CELLULAR SIGNALLING, 2019; 59 (): 62

Abstract

Breast cancer is the most common malignant disease among women worldwide and the novel therapeutic agents are urgently needed. Panobinostat (LBH589), ......

Full Text Link